Invasive and non-invasive investigations for non-alcoholic steatohepatitis: The benefit of histology

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 10, 2005, Pages 1260-

  Ahmed, M H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; AMINOTRANSFERASE; ASCORBIC ACID; BIOLOGICAL MARKER; URSODEOXYCHOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE COURSE; FATTY LIVER; HISTOLOGY; INSULIN RESISTANCE; LETTER; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

FAT NECROSIS; FATTY LIVER; HEPATITIS; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; OBESITY; TRANSAMINASES;

EID: 27144491376     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500329038     Document Type: Letter

References (8)

1. Bruno S, Maisonneuve P, Castellana P, Rotmensz N, Rossi S, Maggioni M, et al. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. Br Med J 2005;23(7497):932.
2. Bauditz J, Schmidt HH, Dippe P, Lochs H, Pirlich M. Non-alcohol induced steatohepatitis in non-obese patients: treatment with ursodeoxycholic acid. Am J Gastroenterol 2004;99: 959-60.
3. Vajro P, Franzese A, Valerio G, Iannucci MP, Aragione N. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 2000;136:739-43.
4. Adams LA, Angulo P. Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy. Am J Gastroenterol 2003;98:2348-50.
5. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8.
6. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;18:1221-31.
7. Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2002;2:11-9.
8. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:E462-8.